一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

Welcome to chemicalbook!
+1 (818) 612-2111
RFQ
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >Biochemical Engineering>Inhibitors>avatrombopag
avatrombopag
  • avatrombopag
  • avatrombopag

avatrombopag NEW

Price $5 $4 $2
Package 1KG 25KG 100KG
Update Time: 2026-07-02

Product Details

Product Name: avatrombopag CAS No.: 570406-98-3
Min. Order: 0.1KG Purity: 99%
Supply Ability: g-kg-tons Release date: 2026/07/02
Lead time: In stock, ready for shipment Delivery: By express, by air, by sea
Origin: Manufacturer, advantage products COA, MSDS: Available, contact us for details
Note: Hot sales Contact: Tina


avatrombopag

Modify Date: 2024-01-02 19:13:10

Article illustration
avatrombopag structure
Common Nameavatrombopag
CAS Number570406-98-3Molecular Weight649.655
Density1.4±0.1 g/cm3Boiling PointN/A
Molecular FormulaC29H34Cl2N6O3S2Melting PointN/A
MSDSN/AFlash PointN/A








PurityQuantityBudgetInquiry

 Use of avatrombopag


Avatrombopag(AKR-501; AS1670542) is a novel orally-active thrombopoietin(TPO) receptor agonist with EC50 of 3.3 nM.EC50 value: 3.3 nM [1]Target: TPO receptor agonistin vitro: AKR-501 specifically targeted the TPO receptor and stimulated megakaryocytopoiesis throughout the development and maturation of megakaryocytes just as rhTPO did. AKR-501, however, was shown to be effective only in humans and chimpanzees with high species specificity [1]. AS1670542 has 50% effective concentration values for cell proliferation with AS1670542 or eltrombopag were 1.9 and 13nM, respectively, while those for megakaryocyte colony formation from human cord blood CD34(+) cells with AS1670542 or eltrombopag were 260 and 950nM, respectively [2].in vivo: Daily oral administration of AKR-501 dose-dependently increased the number of human platelets in in human platelet producing non-obese diabetic/severe combined immunodeficiency (NOD/SCID) mice transplanted with human fetal liver CD34(+) cells, with significance achieved at doses of 1 mg/kg and above. The peak unbound plasma concentrations of AKR-501 after administration at 1 mg/kg in NOD/SCID mice were similar to those observed following administration of an active oral dose in human subjects [1]. AS1670542 significantly increased the number of human platelets in non-obese diabetic/severe combined immunodeficiency (NOD/SCID) mice with transplanted human hematopoietic stem cells at 0.3 (P<0.05); in contrast, while administration of eltrombopag also increased the numbers of these platelets at 30mg/kg/day (P=0.058), no statistical significance was noted in the increase [2].

 Names

Name1-[3-chloro-5-[[4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)-1,3-thiazol-2-yl]carbamoyl]pyridin-2-yl]piperidine-4-carboxylic acid
SynonymMore Synonyms

 avatrombopag Biological Activity

DescriptionAvatrombopag(AKR-501; AS1670542) is a novel orally-active thrombopoietin(TPO) receptor agonist with EC50 of 3.3 nM.EC50 value: 3.3 nM [1]Target: TPO receptor agonistin vitro: AKR-501 specifically targeted the TPO receptor and stimulated megakaryocytopoiesis throughout the development and maturation of megakaryocytes just as rhTPO did. AKR-501, however, was shown to be effective only in humans and chimpanzees with high species specificity [1]. AS1670542 has 50% effective concentration values for cell proliferation with AS1670542 or eltrombopag were 1.9 and 13nM, respectively, while those for megakaryocyte colony formation from human cord blood CD34(+) cells with AS1670542 or eltrombopag were 260 and 950nM, respectively [2].in vivo: Daily oral administration of AKR-501 dose-dependently increased the number of human platelets in in human platelet producing non-obese diabetic/severe combined immunodeficiency (NOD/SCID) mice transplanted with human fetal liver CD34(+) cells, with significance achieved at doses of 1 mg/kg and above. The peak unbound plasma concentrations of AKR-501 after administration at 1 mg/kg in NOD/SCID mice were similar to those observed following administration of an active oral dose in human subjects [1]. AS1670542 significantly increased the number of human platelets in non-obese diabetic/severe combined immunodeficiency (NOD/SCID) mice with transplanted human hematopoietic stem cells at 0.3 (P<0.05); in contrast, while administration of eltrombopag also increased the numbers of these platelets at 30mg/kg/day (P=0.058), no statistical significance was noted in the increase [2].
Related Catalog
Signaling Pathways >> Immunology/Inflammation >> Thrombopoietin Receptor
Research Areas >> Inflammation/Immunology
References

[1]. Fukushima-Shintani M, et al. AKR-501 (YM477) a novel orally-active thrombopoietin receptor agonist. Eur J Haematol. 2009 Apr;82(4):247-54.

[2]. Abe M, et al. Pharmacological profile of AS1670542, a novel orally-active human thrombopoietin receptor agonist. Eur J Pharmacol. 2011 Jan 10;650(1):58-63.

 Chemical & Physical Properties

Density1.4±0.1 g/cm3
Molecular FormulaC29H34Cl2N6O3S2
Molecular Weight649.655
Exact Mass648.151062
PSA161.87000
LogP6.82
Index of Refraction1.671
Storage condition2-8℃

 Synonyms



Company Profile


Our company is a high-tech enterprise specializing in chemical raw materials such as electronic materials, optoelectronic materials, semiconductor materials, UV monomers, silane catalysts, cosmetic raw materials, etc. The company integrates research and development, production, customized synthesis, and sales, and is committed to providing customers with high-quality chemical product solutions.



Our Company

Article illustrationArticle illustration


Our Advantage

Rich experience

Our products have been exported to many countries, including Germany, Spain, the United Kingdom, the United States, Australia, the Middle East, Asia, and more. We have received highly positive feedback from our clients and have established long-term friendly cooperative relationships with them.

Excellent quality, purity, and competitive price

Excellent quality is one of the cornerstones of our success. We welcome ordering samples for quality testing.

Article illustration

Safe and fast delivery

We will arrange shipment of spot products as soon as we receive payment.

Customized products are determined based on the synthesis time of different products.

 

Excellent pre-sales and after-sales service

Pre sales:

We are committed to providing the most favorable quotes and detailed information about our products and company.

after-sale service:

We assist buyers in customs clearance by providing necessary documents and information.

If there is any dispute over product quality, we are committed to providing the best solution.

 

? Packaging: 

1kg/bag, 25kg/drum, 50kg/drum, 180kg/drum, 200kg/drum, 1T/bag/drum, standard export packaging or packaging required by customers


Article illustrationArticle illustration

Shipping

Article illustration

? Delivery:

Within 7 days after receiving your payment


Contact information

For more details, pls contact us freely.

Contact name: Tina

Email address: Tina@fdachem.com

Mob: 86 13213167925

WhatsApp/Skype/Wechat/LINE: 86 15225627621




Company Profile Introduction

Our company is a high-tech enterprise specializing in chemical raw materials such as electronic materials, optoelectronic materials, semiconductor materials, UV monomers, silane catalysts, cosmetic raw materials, etc. The company integrates research and development, production, customized synthesis, and sales, and is committed to providing customers with high-quality chemical product solutions. With our agile custom synthesis capabilities and responsive supply chain system, our products have gained widespread adoption across Asian markets including Japan, South Korea, Singapore, and Malaysia, while also expanding deeply into Europe and the Americas. We have forged long-term strategic partnerships with numerous leading global enterprises in the sector. "Driving value through technology and earning trust through service" is our core mission. Looking ahead, we will continue to focus on technological breakthroughs and green innovation in new materials, collaborating with partners to build a high-quality industrial ecosystem and provide globally competitive solutions with greater foresight.

You may like

Recommended supplier

Product name Price   Suppliers Update time
$52.00
VIP6Y
TargetMol Chemicals Inc.
2026-05-11
VIP3Y
ShenZhen H&D Pharmaceutical Technology Co., LTD
2026-03-12
VIP7Y
Zison Pharmaceutical (Shandong) Co., Ltd.
2025-12-15
$1.10
VIP6Y
Dideu Industries Group Limited
2025-11-18
Nanjing Kaitian Chemical Co., LTD
2025-09-16
$1.00
VIP7Y
Career Henan Chemical Co
2020-02-17
彭山县| 赫章县| 广西| 黑山县| 连南| 神农架林区| 贵德县| 启东市| 永德县| 山阳县| 巫溪县| 平舆县| 鹿泉市| 揭阳市| 方山县| 雷州市| 辽宁省| 西畴县| 博白县| 阿拉尔市| 凤城市| 清新县| 霍城县| 诏安县| 盈江县| 宁晋县| 弋阳县| 象州县| 文水县| 柞水县| 大田县| 凤阳县| 嵊泗县| 涿鹿县| 来宾市| 丰台区| 靖宇县| 旬阳县| 斗六市| 蒙自县| 潞城市|